1. Home
  2. NBY vs SNES Comparison

NBY vs SNES Comparison

Compare NBY & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$2.77

Market Cap

6.3M

Sector

N/A

ML Signal

HOLD

Logo SenesTech Inc.

SNES

SenesTech Inc.

N/A

Current Price

$2.57

Market Cap

14.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NBY
SNES
Founded
2000
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
14.5M
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
NBY
SNES
Price
$2.77
$2.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
467.3K
50.4K
Earning Date
11-07-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$10,302,000.00
$2,301,000.00
Revenue This Year
$23.91
$41.52
Revenue Next Year
$32.05
$77.28
P/E Ratio
$114.24
N/A
Revenue Growth
390.34
39.37
52 Week Low
$0.46
$1.30
52 Week High
$4.44
$6.24

Technical Indicators

Market Signals
Indicator
NBY
SNES
Relative Strength Index (RSI) 85.94 38.59
Support Level $1.00 $2.70
Resistance Level $1.11 $2.94
Average True Range (ATR) 0.30 0.21
MACD 0.21 0.03
Stochastic Oscillator 90.14 9.80

Price Performance

Historical Comparison
NBY
SNES

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Share on Social Networks: